Prince Pharmaceutical Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	152.62	102.8	122.57	71.96	72.5
Cash & Short-Term Investments	152.62	102.8	122.57	71.96	72.5
Cash Growth	48.46%	-16.12%	70.33%	-0.74%	27.02%
Accounts Receivable	197.13	116.63	108.7	72.65	62.44
Receivables	197.13	116.63	108.7	72.65	62.44
Inventory	205.57	142.37	142.12	149.86	125.44
Prepaid Expenses	-	2.34	-	-	-
Other Current Assets	5.58	0.98	18.01	7.22	14.91
Total Current Assets	560.89	365.13	391.39	301.68	275.29
Property, Plant & Equipment	932.72	973.6	999.83	969.34	979.79
Other Intangible Assets	0.5	0.45	1.3	1.51	2.02
Long-Term Deferred Tax Assets	2.75	2.29	3.83	3.26	15.85
Other Long-Term Assets	6.62	6.78	14.59	28.49	17.69
Total Assets	1,503	1,348	1,411	1,304	1,291
Accounts Payable	155.02	108.06	84.83	55.37	68.46
Accrued Expenses	-	39.98	-	-	-
Short-Term Debt	63.14	30	30	30	60
Current Portion of Long-Term Debt	-	32.35	31.76	31.43	16.91
Current Portion of Leases	4.93	8.07	5.01	6.97	3.19
Current Income Taxes Payable	8.84	-	4.35	-	-
Current Unearned Revenue	4.3	5.45	2.62	14.78	10.91
Other Current Liabilities	73.67	10.81	53.38	51.61	41.67
Total Current Liabilities	309.91	234.71	211.94	190.16	201.14
Long-Term Debt	234.13	267.27	299.49	330.92	362.06
Long-Term Leases	119.83	123.11	124.1	123.78	123.83
Long-Term Deferred Tax Liabilities	0.95	1.1	0.93	1.05	0.74
Total Liabilities	664.81	626.19	636.47	645.91	687.77
Common Stock	374.1	366.05	361.93	331.93	331.93
Additional Paid-In Capital	368.67	363.93	348.49	282.22	279.29
Retained Earnings	95.91	-7.92	53.81	44.23	-8.36
Comprehensive Income & Other	-	-	10.24	-	-
Shareholders' Equity	838.68	722.06	774.47	658.38	602.87
Total Liabilities & Equity	1,503	1,348	1,411	1,304	1,291
Total Debt	422.03	460.8	490.36	523.11	565.99
Net Cash (Debt)	-269.41	-357.99	-367.79	-451.15	-493.49
Net Cash Per Share	-7.30	-9.79	-10.06	-13.54	-14.87
Filing Date Shares Outstanding	36.92	36.61	36.19	33.19	33.19
Total Common Shares Outstanding	36.92	36.61	36.19	33.19	33.19
Working Capital	250.98	130.42	179.45	111.52	74.15
Book Value Per Share	22.71	19.73	21.40	19.83	18.16
Tangible Book Value	838.17	721.61	773.16	656.86	600.85
Tangible Book Value Per Share	22.70	19.71	21.36	19.79	18.10
Land	-	102.92	102.92	102.92	102.92
Buildings	-	580.78	580.78	578.84	578.62
Machinery	-	462.94	441.82	365.91	336.1

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.